| 7.6 |
22.8 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 6.4 |
19.1 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 4.4 |
22.0 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 3.7 |
11.2 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 3.6 |
10.9 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 2.9 |
8.8 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 2.9 |
8.7 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.8 |
8.4 |
GO:0090187 |
zymogen granule exocytosis(GO:0070625) positive regulation of pancreatic juice secretion(GO:0090187) |
| 2.7 |
8.1 |
GO:0042939 |
renal sodium ion transport(GO:0003096) glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 2.5 |
7.6 |
GO:0060437 |
lung growth(GO:0060437) |
| 2.5 |
14.9 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 2.4 |
9.8 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 2.4 |
9.6 |
GO:2000313 |
ureteric bud formation(GO:0060676) fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 2.2 |
10.9 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 2.1 |
8.5 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 2.0 |
6.1 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 2.0 |
8.1 |
GO:1904192 |
prostate gland stromal morphogenesis(GO:0060741) cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 2.0 |
11.9 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 2.0 |
7.9 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 1.9 |
5.8 |
GO:0060915 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 1.9 |
13.3 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 1.7 |
13.9 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 1.7 |
32.1 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 1.6 |
4.8 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.6 |
6.4 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 1.6 |
7.8 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 1.4 |
4.3 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 1.4 |
11.4 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 1.4 |
6.9 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 1.4 |
12.5 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 1.4 |
5.5 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 1.4 |
4.1 |
GO:2000256 |
positive regulation of male germ cell proliferation(GO:2000256) |
| 1.3 |
7.8 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 1.3 |
5.2 |
GO:0050904 |
diapedesis(GO:0050904) |
| 1.3 |
3.8 |
GO:0046544 |
regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) development of secondary male sexual characteristics(GO:0046544) response to interleukin-15(GO:0070672) |
| 1.2 |
4.9 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 1.1 |
2.3 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 1.1 |
10.1 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 1.1 |
12.2 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 1.1 |
5.4 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 1.1 |
10.8 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 1.1 |
5.3 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 1.0 |
4.1 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 1.0 |
5.0 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 1.0 |
3.9 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 1.0 |
3.9 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.9 |
7.5 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.9 |
7.3 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.9 |
2.7 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.8 |
3.2 |
GO:0042637 |
catagen(GO:0042637) |
| 0.8 |
12.0 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.8 |
2.4 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.8 |
30.2 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.8 |
4.0 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.8 |
2.3 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.8 |
3.1 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.7 |
4.4 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.7 |
4.8 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.7 |
13.1 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.7 |
5.9 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) regulation of mesenchymal cell apoptotic process(GO:2001053) negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.7 |
20.2 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.6 |
1.9 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.6 |
7.5 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.6 |
1.9 |
GO:0021943 |
calcium-independent cell-matrix adhesion(GO:0007161) formation of radial glial scaffolds(GO:0021943) |
| 0.6 |
6.5 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.6 |
1.8 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.6 |
1.8 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.6 |
2.8 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.6 |
7.2 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.6 |
3.9 |
GO:1904707 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.6 |
6.6 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.5 |
5.9 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.5 |
5.4 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.5 |
1.6 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.5 |
4.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.5 |
5.7 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.5 |
2.0 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.5 |
2.5 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.5 |
6.1 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.5 |
1.5 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.5 |
3.8 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.5 |
1.8 |
GO:0010878 |
cholesterol storage(GO:0010878) |
| 0.5 |
3.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.5 |
3.2 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.5 |
2.7 |
GO:0048597 |
post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.4 |
1.3 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.4 |
2.6 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.4 |
2.6 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.4 |
4.7 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.4 |
4.2 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.4 |
3.0 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.4 |
12.7 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.4 |
1.2 |
GO:0022605 |
oogenesis stage(GO:0022605) |
| 0.4 |
8.0 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.4 |
7.9 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.4 |
13.4 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.4 |
1.6 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.4 |
1.6 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.4 |
4.3 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.4 |
2.3 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.4 |
1.2 |
GO:0051311 |
meiotic metaphase plate congression(GO:0051311) |
| 0.4 |
6.6 |
GO:0001946 |
lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.4 |
2.1 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.4 |
2.1 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.3 |
2.3 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.3 |
1.9 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 |
2.6 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.3 |
1.9 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.3 |
1.2 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.3 |
6.1 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.3 |
0.8 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 |
3.2 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.3 |
0.8 |
GO:0046671 |
positive regulation of neuron maturation(GO:0014042) regulation of cellular pH reduction(GO:0032847) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.3 |
2.6 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.2 |
1.7 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.2 |
5.9 |
GO:1901343 |
negative regulation of angiogenesis(GO:0016525) negative regulation of vasculature development(GO:1901343) negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.2 |
0.4 |
GO:0051462 |
cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.2 |
4.0 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
8.6 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.2 |
1.1 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.2 |
0.4 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.2 |
1.0 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 |
1.6 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.2 |
2.4 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.2 |
3.7 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.2 |
4.5 |
GO:0035066 |
positive regulation of histone acetylation(GO:0035066) |
| 0.2 |
1.7 |
GO:0050680 |
negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.2 |
3.9 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.2 |
0.7 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.2 |
1.3 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
0.9 |
GO:1904690 |
adenosine to inosine editing(GO:0006382) regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.2 |
0.5 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.2 |
0.7 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 |
1.6 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.2 |
2.4 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 |
0.8 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.2 |
3.5 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.2 |
6.8 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 0.2 |
0.9 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.2 |
5.8 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.2 |
1.4 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.2 |
2.7 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 |
6.4 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
1.3 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
2.9 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
1.6 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
2.8 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
3.2 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.1 |
0.3 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.1 |
1.5 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.1 |
3.8 |
GO:0043149 |
contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.1 |
1.9 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
3.3 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.1 |
6.4 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.1 |
5.1 |
GO:0051567 |
histone H3-K9 methylation(GO:0051567) |
| 0.1 |
0.9 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.1 |
18.9 |
GO:0010631 |
epithelial cell migration(GO:0010631) |
| 0.1 |
0.4 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.1 |
14.8 |
GO:0014013 |
regulation of gliogenesis(GO:0014013) |
| 0.1 |
0.9 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.7 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 |
1.9 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 |
7.4 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.1 |
0.8 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
0.5 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.8 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
1.6 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.3 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.4 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
1.9 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.8 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
2.6 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.1 |
1.9 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.8 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.1 |
0.6 |
GO:0007220 |
Notch receptor processing(GO:0007220) membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
3.6 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.1 |
0.9 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.8 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.1 |
1.6 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.1 |
3.1 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.1 |
0.3 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.1 |
0.9 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.4 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 |
0.8 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.4 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.1 |
0.2 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
5.1 |
GO:0007160 |
cell-matrix adhesion(GO:0007160) |
| 0.1 |
3.0 |
GO:0007569 |
cell aging(GO:0007569) |
| 0.1 |
0.6 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
1.8 |
GO:0006805 |
xenobiotic metabolic process(GO:0006805) |
| 0.1 |
0.2 |
GO:0032962 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.1 |
0.3 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.1 |
1.8 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
5.1 |
GO:0006664 |
glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
| 0.1 |
6.6 |
GO:0000082 |
G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.1 |
0.3 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.2 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.0 |
0.8 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.2 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.0 |
0.2 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 |
1.5 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.0 |
0.9 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.2 |
GO:0060395 |
SMAD protein signal transduction(GO:0060395) |
| 0.0 |
0.2 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.0 |
1.5 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.2 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.0 |
1.5 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.0 |
0.9 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
0.1 |
GO:0046929 |
negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.0 |
0.1 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.2 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
1.7 |
GO:0015758 |
glucose transport(GO:0015758) |
| 0.0 |
3.0 |
GO:0060348 |
bone development(GO:0060348) |
| 0.0 |
1.2 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.0 |
0.4 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.0 |
1.3 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
2.5 |
GO:0006260 |
DNA replication(GO:0006260) |
| 0.0 |
0.2 |
GO:0003014 |
renal system process(GO:0003014) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |